News

Article

Eurofins MWG Operon Launches Ion Proton Sequencing Services

Author(s):

Eurofins MWG Operon expands its exome sequencing services with the Ion Proton Next Generation Sequencer.

Eurofins MWG Operon has expanded its exome sequencing services with the Ion Proton Next Generation Sequencer.
Certification for Ion AmpliSeq Exome sequencing was also awarded after joining Life Technologies Corporation's Ion AmpliSeq Exome Certified Service Provider program (CSP). Using Life Technologies proprietary approach, consisting of the Ion AmpliSeq Exome Kit, the Ion Proton Sequencer and Ion Reporter Software, provides researchers with a fast, and cost-effective exome sequencing solution available with flexible throughput, according to the company.

Source: Eurofins MWG Operon

Newsletter

Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.

Related Videos
Understanding the Operational Impacts of the 15% US-EU Pharma Tariff Cap
Dave Miller, PhD, Chief Scientific Officer, AustinPx